DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Benhamou Y, Pockros P, Rodriquez-Torres M. et al.
The safety and efficacy of viramidine plus pegylated interferon alfa-2b versus ribavirin plus pegylated interferon alfa-2b in therapy-naïve patients infected with HCV: phase 3 results
J Hepatol 2006; 44(suppl 2): S273-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.